CompanyGraphAt a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- PositionGross margin is 23.5%, lower than 95% of its Scientific & Technical Instruments peers (median 38.1%)
- FinancialsAltman Z-Score 8.35: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.41BCNY505.56M · vs all stocks (USD)
Revenue (TTM)
325.25MCNY48.23M · vs all stocks (USD)
Profit Margin
-10.97%vs Scientific & Technical Instruments peers
Beta
-0.0180xvs all stocks
52-Week Change
-45.51%vs all stocks
Market Capitalization
3.41BCNY505.56M · vs all stocks (USD)
Enterprise Value
3.12BCNY462.19M · vs all stocks (USD)
Price to Sales (TTM)
10.17xvs Scientific & Technical Instruments peers
Price to Book (MRQ)
4.27xvs Scientific & Technical Instruments peers
Enterprise to Revenue
9.58xvs Scientific & Technical Instruments peers
Gross Margin
23.53%vs Scientific & Technical Instruments peers
Profit Margin
-10.97%vs Scientific & Technical Instruments peers
Operating Margin
-5.45%vs Scientific & Technical Instruments peers
Return on Assets (TTM)
-1.32%vs Scientific & Technical Instruments peers
Return on Equity (TTM)
-5.60%vs Scientific & Technical Instruments peers
Revenue (TTM)
325.25MCNY48.23M · vs all stocks (USD)
Revenue per Share (TTM)
0.2520CNYUpdated Aug 19, 2026Quarterly Revenue Growth
12.40%vs Scientific & Technical Instruments peers
Gross Profit (TTM)
82.45MCNY12.23M · vs all stocks (USD)
EBITDA (TTM)
28.18MCNY4.18M · vs all stocks (USD)
Net Income (TTM)
-35.67MCNY-5.29M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-15.64%vs Scientific & Technical Instruments peers
Operating Cash Flow (TTM)
3.21MCNY476.47K · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-79.71MCNY-11.82M · vs all stocks (USD)
Payout Ratio
0.00%vs Scientific & Technical Instruments peers
Minority Interest (Equity)
8.81MCNYFY2025 · Dec 31, 2025Revenue
317.37MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
230.95MCNYFY2025 · Dec 31, 2025Gross Profit
86.42MCNYFY2025 · Dec 31, 2025Operating Income
-3.36MCNY-497.58K · vs all stocks (USD)
Pre-tax Income
-31.63MCNYFY2025 · Dec 31, 2025Income Tax Expense
2.93MCNYFY2025 · Dec 31, 2025Net Income
-34.55MCNYFY2025 · Dec 31, 2025EBIT
-28.58MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
28.18MCNYFY2025 · Dec 31, 2025Research & Development
11.35MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
32.43MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.29MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
3.05MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0256CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0256CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.28BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.28BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-34.55MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.83MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-61.43MCNYFY2025 · Dec 31, 2025Free Cash Flow
-93.51MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
275.65MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-34.55MCNYFY2025 · Dec 31, 2025Other Non-cash Items
11.84MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-9.19MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-29.52MCNYFY2025 · Dec 31, 2025Capital Expenditures
-32.08MCNYFY2025 · Dec 31, 2025Net Acquisitions
-15.42MCNYFY2025 · Dec 31, 2025Purchase of Investments
-300.00KCNYFY2025 · Dec 31, 2025Sale of Investments
35.00KCNYFY2025 · Dec 31, 2025Other Investing Activity
-50.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-97.77MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
58.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-64.20MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.73MCNYFY2025 · Dec 31, 2025Other Financing Charges
203.42MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
195.49MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.28BSharesUpdated Aug 19, 2026Float Shares
1.19BSharesUpdated Aug 19, 2026% Held by Insiders
21.59%vs all stocks
% Held by Institutions
0.03%vs all stocks
Total Cash (MRQ)
264.98MCNY39.30M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.2080CNYUpdated Aug 19, 2026Total Debt (MRQ)
66.99MCNY9.93M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0857xvs Scientific & Technical Instruments peers
Current Ratio (MRQ)
3.11xvs Scientific & Technical Instruments peers
Book Value per Share (MRQ)
0.6060CNYUpdated Aug 19, 2026Total Assets
1.05BCNY155.68M · vs all stocks (USD)
Total Current Assets
603.55MCNYFY2025 · Dec 31, 2025Total Liabilities
265.02MCNYFY2025 · Dec 31, 2025Total Non-current Assets
446.23MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
30.22MCNYFY2025 · Dec 31, 2025Total Current Liabilities
234.80MCNYFY2025 · Dec 31, 2025Cash
275.54MCNYFY2025 · Dec 31, 2025Cash Equivalents
50.37MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
325.91MCNYFY2025 · Dec 31, 2025Accounts Receivable
88.42MCNYFY2025 · Dec 31, 2025Inventory
116.39MCNYFY2025 · Dec 31, 2025Accounts Payable
65.48MCNYFY2025 · Dec 31, 2025Short-term Debt
78.72MCNYFY2025 · Dec 31, 2025Other Current Liabilities
8.89MCNYFY2025 · Dec 31, 2025Long-term Debt
7.73MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
5.52MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.28BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
784.77MCNY116.38M · vs all stocks (USD)
Treasury Stock
45.50MCNYFY2025 · Dec 31, 202552-Week Low
1.99CNYUpdated Aug 19, 202652-Week High
5.79CNYUpdated Aug 19, 202652-Week Change
-45.51%vs all stocks
Beta
-0.0180xvs all stocks
50-Day MA
2.43CNYUpdated Aug 19, 2026200-Day MA
3.35CNYUpdated Aug 19, 2026Avg 10-Day Volume
21.50MSharesUpdated Aug 19, 2026Avg 30-Day Volume
30.75MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.0300CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 23.5%, lower than 95% of its Scientific & Technical Instruments peers (median 38.1%)Significant
Gross margin: 0.24Industry median: 0.38Industry P5: 0.24Peers compared: 64.00
Financial Health
Altman Z-Score 8.35: safe zoneNotable
Altman Z-Score: 8.35
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Brisa Bridgestone Sabancı Lastik Sanayi ve Ticaret A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Hengxing New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Gunkul Engineering Public Company Limited
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Yalian Machinery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Qingdao Huijintong Power Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Hangzhou Flariant Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Guangdong Sitong Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Penyao Environmental Protection Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Chengdu KSW Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Wuhu Fuchun Dye & Weave Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
ImmuPharma PLC
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Innodata Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
IonQ, Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated